CSL Behring to become latest partner in BaseLaunch Phase II

BaseLaunch, the Basel Area-based biotech venture accelerator and incubator, today announces that CSL Behring, a leading global biotechnology company focused on discovering, developing and delivering medicines for people with rare and serious diseases, becomes the fifth partner in BaseLaunch Phase II, the next phase in BaseLaunch’s company building activities.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...